Researcher profile

Jinjiang Guo

Jinjiang Guo contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
6works
0followers
7topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

6 published item(s)

preprint2026arXiv

Do Larger Models Really Win in Drug Discovery? A Benchmark Assessment of Model Scaling in AI-Driven Molecular Property and Activity Prediction

The rapid growth of molecular foundation models and large language models has encouraged a scale centred view of AI in drug discovery, in which larger pretrained models are expected to supersede compact cheminformatics models and graph neural networks (GNNs) trained for individual tasks. We test this assumption across 26 endpoints for molecular properties, toxicity, safety liabilities and biological activity, grouped into ADME, toxicity and bioactivity classes. The benchmark contains 78 endpoint and split entries spanning random, Murcko scaffold and structure separated 5-fold CV. Ordered from easiest to hardest, these splits approximate retrospective evaluation on a closed library, scaffold expansion in hit to lead, and library expansion on novel chemotypes. Each entry includes ML, GNN, pretrained molecular sequence and LLM based SAR families. Across 156 fold mean comparisons, classical ML such as RF(ECFP4) and ExtraTrees(RDKit) win 116, GNNs such as GIN and Ligandformer win 25, pretrained sequence models such as MoLFormer and ChemBERTa2 win 12, and LLM based SAR baselines win three. ML dominates random split interpolation but loses part of this advantage under harder splits; GNN and sequence models also decline but gain relative ground, whereas LLM based SAR is weaker in absolute terms yet less sensitive to the split axis. Paired bootstrap analyses support family level trends more strongly than individual model rankings. SAR knowledge derived from training folds improves many GPT5.5-SAR and Opus4.7-SAR metrics but does not make rule based reasoning a universal substitute for supervised predictors. Compact specialized models remain highly effective for molecular property and activity prediction. Larger models add value for SAR interpretation and reasoning in low data settings, but predictive performance depends on the fit among model, task and validation scenario, not on scale alone.

preprint2022arXiv

Heterogeneous Graph based Deep Learning for Biomedical Network Link Prediction

Multi-scale biomedical knowledge networks are expanding with emerging experimental technologies that generates multi-scale biomedical big data. Link prediction is increasingly used especially in bipartite biomedical networks to identify hidden biological interactions and relationshipts between key entities such as compounds, targets, gene and diseases. We propose a Graph Neural Networks (GNN) method, namely Graph Pair based Link Prediction model (GPLP), for predicting biomedical network links simply based on their topological interaction information. In GPLP, 1-hop subgraphs extracted from known network interaction matrix is learnt to predict missing links. To evaluate our method, three heterogeneous biomedical networks were used, i.e. Drug-Target Interaction network (DTI), Compound-Protein Interaction network (CPI) from NIH Tox21, and Compound-Virus Inhibition network (CVI). Our proposed GPLP method significantly outperforms over the state-of-the-art baselines. In addition, different network incompleteness is analysed with our devised protocol, and we also design an effective approach to improve the model robustness towards incomplete networks. Our method demonstrates the potential applications in other biomedical networks.

preprint2022arXiv

Sequence-based deep learning antibody design for in silico antibody affinity maturation

Antibody therapeutics has been extensively studied in drug discovery and development within the past decades. One increasingly popular focus in the antibody discovery pipeline is the optimization step for therapeutic leads. Both traditional methods and in silico approaches aim to generate candidates with high binding affinity against specific target antigens. Traditional in vitro approaches use hybridoma or phage display for candidate selection, and surface plasmon resonance (SPR) for evaluation, while in silico computational approaches aim to reduce the high cost and improve efficiency by incorporating mathematical algorithms and computational processing power in the design process. In the present study, we investigated different graph-based designs for depicting antibody-antigen interactions in terms of antibody affinity prediction using deep learning techniques. While other in silico computations require experimentally determined crystal structures, our study took interest in the capability of sequence-based models for in silico antibody maturation. Our preliminary studies achieved satisfying prediction accuracy on binding affinities comparing to conventional approaches and other deep learning approaches. To further study the antibody-antigen binding specificity, and to simulate the optimization process in real-world scenario, we introduced pairwise prediction strategy. We performed analysis based on both baseline and pairwise prediction results. The resulting prediction and efficiency prove the feasibility and computational efficiency of sequence-based method to be adapted as a scalable industry practice.

preprint2021arXiv

Enhance Information Propagation for Graph Neural Network by Heterogeneous Aggregations

Graph neural networks are emerging as continuation of deep learning success w.r.t. graph data. Tens of different graph neural network variants have been proposed, most following a neighborhood aggregation scheme, where the node features are updated via aggregating features of its neighboring nodes from layer to layer. Though related research surges, the power of GNNs are still not on-par-with their counterpart CNNs in computer vision and RNNs in natural language processing. We rethink this problem from the perspective of information propagation, and propose to enhance information propagation among GNN layers by combining heterogeneous aggregations. We argue that as richer information are propagated from shallow to deep layers, the discriminative capability of features formulated by GNN can benefit from it. As our first attempt in this direction, a new generic GNN layer formulation and upon this a new GNN variant referred as HAG-Net is proposed. We empirically validate the effectiveness of HAG-Net on a number of graph classification benchmarks, and elaborate all the design options and criterions along with.

preprint2021arXiv

Real-time tracking of COVID-19 and coronavirus research updates through text mining

The novel coronavirus (SARS-CoV-2) which causes COVID-19 is an ongoing pandemic. There are ongoing studies with up to hundreds of publications uploaded to databases daily. We are exploring the use-case of artificial intelligence and natural language processing in order to efficiently sort through these publications. We demonstrate that clinical trial information, preclinical studies, and a general topic model can be used as text mining data intelligence tools for scientists all over the world to use as a resource for their own research. To evaluate our method, several metrics are used to measure the information extraction and clustering results. In addition, we demonstrate that our workflow not only have a use-case for COVID-19, but for other disease areas as well. Overall, our system aims to allow scientists to more efficiently research coronavirus. Our automatically updating modules are available on our information portal at https://ghddi-ailab.github.io/Targeting2019-nCoV/ for public viewing.

preprint2021arXiv

Subjective and Objective Visual Quality Assessment of Textured 3D Meshes

Objective visual quality assessment of 3D models is a fundamental issue in computer graphics. Quality assessment metrics may allow a wide range of processes to be guided and evaluated, such as level of detail creation, compression, filtering, and so on. Most computer graphics assets are composed of geometric surfaces on which several texture images can be mapped to 11 make the rendering more realistic. While some quality assessment metrics exist for geometric surfaces, almost no research has been conducted on the evaluation of texture-mapped 3D models. In this context, we present a new subjective study to evaluate the perceptual quality of textured meshes, based on a paired comparison protocol. We introduce both texture and geometry distortions on a set of 5 reference models to produce a database of 136 distorted models, evaluated using two rendering protocols. Based on analysis of the results, we propose two new metrics for visual quality assessment of textured mesh, as optimized linear combinations of accurate geometry and texture quality measurements. These proposed perceptual metrics outperform their counterparts in terms of correlation with human opinion. The database, along with the associated subjective scores, will be made publicly available online.